Screen natural terpenoids to identify potential Jab1 inhibitors for treating breast cancer

Abstract

Jab1 (c-Jun activation domain-binding protein-1) overexpression has been extensively linked to cancer development (or metastasis) in various malignancies by positively regulating cancer cell proliferation or inactivating several tumor suppressors. Recent research has focused on utilizing plant products to target crucial elements of dysregulated signaling pathways to elucidate a potent cancer therapeutic approach. Terpenoids have shown significant anti-inflammatory and anti-cancerous properties in a broader range of carcinomas by inducing apoptosis. Through an extensive literature search, we have selected only those terpenoids (from the NPACT database) that have not been explored against Jab1 (CSN5, COP9 signalosome subunit 5) in breast cancer for our research study. We have used two docking servers, PATCH DOCK, and CB DOCK, to find the binding interaction between selected terpenoids and Jab1. Further, we have also used SWISS ADME to investigate the pharmacokinetics of selected ligands. Amongst all selected ligands, lutein (belongs to the xanthophylls class) has displayed maximum binding energy in both CB Dock and Patch Dock analysis. Hence, our preliminary in silico results have shown lutein as the potent lead candidate for developing a better drug against breast cancer. However, more in silico and in vitro studies are still needed to validate the inhibitory potential of lutein terpenoid against Jab1 in breast cancer.

The Anticancer Activities of Natural Terpenoids That Inhibit Both Melanoma and Non-Melanoma Skin Cancers

“…They are frequently used in traditional medicines in the form of teas or crude extracts. Terpenoids can be classified into subclasses according to the number of isoprene units, such as hemiterpenoids (C5), monoterpenoids (C10), sesquiterpenoids (C15), diterpenoids (C20), triterpenoids (C30), tetraterpenoids (C40), including carotenoids, and polyterpenoids (C5)n. Many terpenoids are reported to have an anti-cancerous effect against breast, gastric, and colorectal cancers [18][19][20][21]. Some terpenoids are already being used for treating cancers.…”

Editorial review on Vol. 7 No. 1

“…This issue also explores the role of β-hydroxybutyric acid (β-HBA) in energy metabolism in cancer treatment, which can become a new type of targeted cancer therapy according to Jianshe Yang et al from Tongji University School of Medicine [2] . In the article "Screen natural terpenoids to identify potential Jab1 inhibitors for treating breast cancer" [3] , the authors explored the inhibitory potential of natural terpenoid inhibitors against Jab1 in breast cancer. The corresponding author, Fahad Khan, is a highly motivated and innovative biotechnologist with specialization in animal cell culture, cancer biology, phytomedicine and molecular biology, with 17,111 Sum of Times Cited referred to WoS.…”